Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 20.56B | 17.54B | 25.29B | 20.50B | 12.42B | 14.97B |
Gross Profit | 6.76B | 5.33B | 8.48B | 6.64B | 4.47B | 5.18B |
EBITDA | 1.63B | 1.75B | 4.04B | 2.84B | 1.67B | 1.31B |
Net Income | 1.05B | -72.80M | 2.29B | 1.57B | 707.17M | -206.22M |
Balance Sheet | ||||||
Total Assets | 42.95B | 42.95B | 39.51B | 35.13B | 29.85B | 29.72B |
Cash, Cash Equivalents and Short-Term Investments | 9.03B | 9.03B | 9.53B | 9.77B | 8.66B | 6.04B |
Total Debt | 8.01B | 8.01B | 5.28B | 5.22B | 4.89B | 4.82B |
Total Liabilities | 12.35B | 12.35B | 10.31B | 9.77B | 7.78B | 7.98B |
Stockholders Equity | 29.61B | 29.61B | 28.30B | 24.60B | 21.38B | 21.07B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -1.85B | 213.32M | 1.12B | 1.79B | -980.43M |
Operating Cash Flow | 0.00 | 765.57M | 1.86B | 1.88B | 2.26B | 602.81M |
Investing Cash Flow | 0.00 | -3.30B | -1.88B | -432.10M | 643.39M | -1.63B |
Financing Cash Flow | 0.00 | 1.30B | -1.18B | -673.55M | -145.99M | 576.89M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥12.21B | 9.59 | 2.23% | 2.63% | 268.28% | ||
80 Outperform | ¥15.89B | 9.07 | 2.21% | 20.91% | 18.64% | ||
75 Outperform | ¥13.12B | 13.60 | 3.02% | 25.64% | ― | ||
71 Outperform | ¥12.71B | 10.07 | 3.68% | -6.96% | -1.72% | ||
58 Neutral | HK$14.03B | 4.45 | -3.01% | 7.32% | 3.67% | -54.16% | |
57 Neutral | ¥12.26B | 15.90 | 2.03% | 25.48% | ― | ||
54 Neutral | ¥12.66B | ― | 5.67% | -6.30% | 34.61% |